Sensus Healthcare Inc

Sensus Healthcare Inc

SRTS · NASDAQ · Healthcare / Medical Devices

2.33USD-0.90 (-27.80%)

Price History

Full chart

Market Stats

Previous Close3.22
Open3.16
Day Range2.31 – 3.28
52-Week Range2.66 – 5.49
Volume194.49K
Market Cap48.40M
P/E (TTM)0.00
Forward P/E21.37
EPS-0.94
Dividend Yield0.00%
Beta1.14
50-Day Avg3.10
200-Day Avg3.69

About

Sensus Healthcare, Inc. operates as a medical device company that manufactures and sells radiation therapy devices to healthcare providers worldwide. The company uses superficial radiation therapy, a low-energy X-ray technology in its portfolio of treatment devices. It offers SRT-100, a photon X-ray low energy superficial radiotherapy system that provides patients an alternative to surgery for treating non-melanoma skin cancers, including basal cell and squamous cell skin cancers, as well as other skin conditions, such as keloids; and SRT-100 Vision, which provides the user with a superficial radiation therapy-tailored treatment planning application that integrates an embedded high frequency ultrasound imaging module, volumetric tumor analysis, beam margins planning, and dosimetry parameters. The company also provides SRT-100 +; Sentinel service program, which offers its customers protection for their systems; and Transdermal Infusion system, a biophysical alternative to infuse high weight molecule modalities into the dermis for medical and aesthetic purposes without the use of needles. In addition, it sells disposable lead shielding replacements; and disposable radiation safety items, such as aprons and eye shields, ultrasound probe film, and disposable applicator tips to treat various sized lesions and various areas of the body. Further, the company distributes laser devices, such as applications for hair removal, vascular lesions, acne treatment, skin toning, and skin rejuvenation, as well as epidermal pigment removal for spots, freckles, and tattoos, as well as provide operational healthcare services for dermatology clinics. It markets its products primarily to private dermatology practices, and radiation oncologists in both private and hospital settings. The company was incorporated in 2010 and is based in Boca Raton, Florida.

Company Details

  • SectorHealthcare
  • IndustryMedical Devices
  • CEOMr. Joseph C. Sardano
  • Employees60
  • Headquarters851 Broken Sound Parkway NW, Boca Raton, FL, United States, 33487, USA
  • Websitehttps://sensushealthcare.com

Leadership

  • Mr. Joseph C. SardanoCo-Founder, Chairman & CEO · b. 1953
  • Mr. Michael J. Sardano J.D.President, Chief Commercial Officer, General Counsel, Corporate Secretary & Director · b. 1988
  • Mr. Javier RampollaChief Financial Officer · b. 1973
  • Ms. Magdalena MartinezChief Operating Officer · b. 1990
  • Mr. Carlton ChowChief Technology Officer · b. 1990
  • Ms. Stephanie TiptonVice President of Marketing

Financials

Income Statement

Currency: USD2013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue10.48M5.81M10.27M14.81M20.59M26.43M27.26M9.58M27.04M44.53M24.41M41.81M27.48M
Growth (%)--44.55%+76.81%+44.17%+39.00%+28.36%+3.16%-64.87%+182.36%+64.68%-45.20%+71.31%-34.26%
Cost of Revenue3.60M2.05M3.70M4.97M6.79M9.52M9.71M4.33M10.05M14.90M10.35M17.38M15.62M
Gross Profit6.88M3.76M6.57M9.85M13.80M16.91M17.56M5.25M16.99M29.63M14.06M24.43M11.87M
Gross Margin65.64%64.63%64.00%66.48%67.03%63.99%64.40%54.81%62.82%66.53%57.61%58.44%43.18%
Operating Expense6.75M7.44M6.80M10.21M17.52M18.92M19.53M13.48M12.87M14.80M14.44M16.34M22.17M
Operating Income126.84K-3.68M-221.26K-363.12K-3.72M-2.01M-1.97M-8.23M4.12M14.83M-382.00K8.09M-10.31M
Operating Margin1.21%-63.34%-2.15%-2.45%-18.06%-7.59%-7.22%-85.98%15.24%33.30%-1.57%19.35%-37.50%
EBITDA393.65K-3.41M96.12K13.00K-3.25M-1.21M-1.15M-6.10M4.73M28.50M1.11M9.45M-9.24M
EBITDA Margin3.76%-58.63%0.94%0.09%-15.80%-4.57%-4.23%-63.69%17.50%64.00%4.56%22.61%-33.61%
Net Income107.63K-3.70M-237.27K-346.45K-3.71M-2.02M-1.70M-6.84M4.12M24.24M485.00K6.65M-7.72M
Net Income Margin1.03%-63.67%-2.31%-2.34%-18.02%-7.65%-6.24%-71.38%15.23%54.44%1.99%15.90%-28.09%
R&D1.33M1.58M1.47M1.82M5.49M6.26M6.42M4.16M3.44M3.46M3.68M4.22M7.78M
R&D as % of Total Revenue12.72%27.14%14.28%12.32%26.67%23.69%23.54%43.42%12.71%7.77%15.07%10.08%28.30%
Interest Expense20.47K20.03K17.79K21.87K68.88K156.69K14.45K14.00K1.00K2.00K0--
Interest Expense % of Total Revenue0.20%0.34%0.17%0.15%0.33%0.59%0.05%0.15%0.00%0.00%0.00%--

Balance Sheet

Currency: USD2013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets-6.94M9.64M18.95M18.84M33.25M36.92M28.01M32.24M56.73M53.71M62.16M53.04M
Total Liabilities-2.80M3.71M3.67M7.15M6.79M8.92M6.51M6.22M8.67M4.87M6.34M4.94M
Total Equity-4.14M5.92M15.27M11.68M26.46M28.00M21.50M26.02M48.07M48.84M55.83M48.10M
Cash-4.54M5.07M5.04M10.09M12.48M8.10M14.91M14.52M25.52M23.15M22.06M22.08M
Total Debt-375.00K422.70K-2.21M-1.43M1.38M225.00K1.02M783.00K602.00K680.00K
Net Debt--4.16M-4.64M-5.04M-7.87M-12.48M-6.68M-13.53M-14.29M-24.50M-22.36M-21.45M-21.40M

Cash Flow

Currency: USD2012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow255.94K-128.69K-1.87M-1.34M-851.02K-3.06M-8.56M-2.11M-434.18K-286.00K-1.41M-2.15M-831.00K528.00K
Investing Cash Flow-143.41K-251.00K-123.96K-196.19K-7.85M6.17M-2.64M-4.90M7.03M129.00K14.84M-187.00K-276.00K-196.00K
Financing Cash Flow2.07M3.25M-45.42K2.06M8.68M1.93M13.60M2.62M210.01K-231.00K-2.43M-40.00K15.00K-305.00K
Capital Expenditure143.41K251.00K123.96K196.19K286.00K287.59K854.83K400.59K358.54K128.00K159.00K229.00K276.00K196.00K
Free Cash Flow112.52K-379.70K-1.99M-1.54M-1.14M-3.34M-9.42M-2.51M-792.72K-414.00K-1.57M-2.37M-1.11M332.00K
Dividends Paid--45.42K2.55M2.55M0--210.34K-731.00K---
FCF to OCF43.96%295.04%106.64%114.65%133.61%109.41%109.98%119.02%182.58%144.76%111.26%110.68%133.21%62.88%
Dividend Paid to FCF---2.28%-166.24%-224.51%0.00%---26.53%--46.53%---

Earnings

Report DateAug 4, 2016Nov 3, 2016Feb 2, 2017May 4, 2017Aug 3, 2017Nov 2, 2017Feb 1, 2018May 3, 2018Aug 2, 2018Nov 1, 2018Feb 14, 2019May 9, 2019Aug 8, 2019Nov 6, 2019Feb 13, 2020May 7, 2020Aug 6, 2020Nov 5, 2020Feb 25, 2021May 6, 2021Aug 5, 2021Nov 4, 2021Feb 10, 2022May 5, 2022Aug 4, 2022Nov 3, 2022Feb 9, 2023May 3, 2023Aug 3, 2023Nov 9, 2023Feb 8, 2024May 10, 2024Aug 8, 2024Nov 14, 2024Feb 5, 2025May 15, 2025Aug 7, 2025Nov 6, 2025Feb 12, 2026May 7, 2026Aug 13, 2026Nov 5, 2026
EPS Estimate--0.01-0.030.01-0.13-0.07-0.08-0.03-0.05-0.06-0.01-0.03-0.04-0.030.03-0.07-0.19-0.14-0.11-0.11-0.06-0.020.160.400.130.130.230.13-0.08-0.020.14-0.040.03-0.010.120.040.01-0.11-0.05-0.11-0.11-0.04
EPS Actual-0.03-0.000.00-0.12-0.06-0.07-0.03-0.08-0.04-0.030.01-0.130.01-0.040.06-0.22-0.16-0.140.02-0.07-0.020.010.320.970.210.110.17-0.12-0.02-0.090.260.140.100.070.09-0.16-0.06-0.06-0.19-0.16-0.18-
Surprise-77.00%108.33%-1300.00%53.85%0.00%62.50%-166.67%20.00%50.00%200.00%-333.33%125.00%-33.33%100.00%-214.29%15.79%0.00%118.18%36.36%66.67%150.00%100.00%142.50%61.54%-15.38%-26.09%-192.31%75.00%-350.00%85.71%450.00%233.33%800.00%-25.00%-500.00%-700.00%45.45%-280.00%-45.45%-63.64%-
TimingPre-marketAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hours

Key Statistics & Ratios

Market Cap48.40M
Enterprise Value35.04M
Trailing P/E0.00
Forward P/E21.37
PEG Ratio0.00
Price / Sales2.76
Price / Book1.35
EPS-0.94
Book Value2.24
Revenue (TTM)17.51M
Gross Profit (TTM)6.37M
EBITDA-12.87M
Profit Margin-88.45%
Operating Margin-138.87%
Return on Equity-34.83%
Return on Assets-16.55%
Shares Outstanding16.46M
Shares Float13.38M
Beta1.14
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%

Analyst Ratings

Buy
Based on 5 analystsTarget 5.38
  • Strong Buy
    2
  • Buy
    3

Ownership Breakdown

Institutions
27.59%
Insiders
18.67%
Retail / Other
53.74%

Top Institutional Holders

  • Pacific Ridge Capital Partners, LLC
    789.67K4.80%
  • Vanguard Capital Management, LLC
    648.23K3.94%
  • Dimensional Fund Advisors, Inc.
    316.12K1.92%
  • Divisadero Street Capital Management, LP
    286.08K1.74%
  • Renaissance Technologies Corp
    252.23K1.53%
  • UBS Group AG
    172.87K1.05%
  • Geode Capital Management, LLC
    165.55K1.01%
  • Meros Investment Management, LP
    152.42K0.93%
  • Sachetta LLC
    152.01K0.92%
  • Greenline Wealth Management LLC
    128.77K0.78%
  • North Star Investment Management Corp
    125.59K0.76%
  • Bank of New York Mellon Corp
    100.41K0.61%
  • Vanguard Fiduciary Trust Co
    75.73K0.46%
  • BlackRock Inc
    71.17K0.43%

Top Fund Holders

  • Vanguard MStar Total Stk Mkt Idx Invest
    494.13K3.00%
  • Adara Smaller Companies
    310.94K1.89%
  • M3Sixty Income and Opportunity Instl
    151.58K0.92%
  • North Star Micro Cap I
    125.59K0.76%
  • Perritt MicroCap Opportunities Investor
    125.59K0.76%
  • DFA US Small Cap I
    75.12K0.46%